HDAC3 and metastatic melanoma: On the other hand, Wilmott et al. [91] demonstrated that HDAC-3 nuclear expression was associated with a better prognosis, while HDAC-8 cytoplasmic overexpression is directly linked with an increased OS in patients with stage IV metastatic melanoma and with positive BRAF/NRAS mutation status [91].